Skip to content

WeCare: A System of Care for Black Youth

Answering the Alarm: A System of Care for Black Youth at Risk for Suicide

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05654207
Acronym
WeCare
Enrollment
2200
Registered
2022-12-16
Start date
2024-04-08
Completion date
2027-04-01
Last updated
2026-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicidal Ideation

Keywords

suicide, ideation, Black youth, depression

Brief summary

The overall goal of this study is to respond to the urgent need for an effective suicide prevention strategy for Black youth by examining the effectiveness of a systems-level strategy to recognize and respond to suicide risk among Black adolescents who present to emergency departments (EDs). The proposed strategy, WeCare, combines combines three components: (1) universal screening using the Computerized Adaptive Screen for Suicidal Youth (CASSY), (2) a brief intervention designed for Black youth with elevated suicide risk in for ED settings, Connections for Safety (CFS), that combines safety planning and strategies to support linkage to outpatient mental health services, and (3) supportive text messages to youth and parent/caregivers for six weeks following the youth's ED visit. Study objectives are (1) to integrate input from multiple stakeholders to inform and facilitate WeCare implementation, and (2) to use a hybrid one effectiveness-implementation design to evaluate its effectiveness.

Detailed description

From 1991 through 2017, suicide attempts increased by 73% among Black high school-aged youth, and suicide attempts requiring hospitalization increased by 122% for Black high school-aged boys. These alarming findings, in part, led to the creation of the Emergency Taskforce on Black Youth Suicide and Mental Health and their subsequent report, Ring the Alarm: The Crisis of Black Youth Suicide in America, and passage of the Pursuing Equity in Mental Act. These all highlight the urgent need to improve suicide risk detection, treatment, and prevention among Black youth. We propose to respond to these challenges and the urgent need for an effective suicide prevention strategy for Black youth by examining the effectiveness of an "easily implementable," "systems-level" strategy to recognize and respond to suicide risk among Black youth who present to EDs. WeCare combines (1) CASSY, a universal screening; (2) CFS, an intervention with elements from SAFETY-Acute (SAFETY-A), an evidence-based, family-centered intervention to safety planning for children and adolescents; (3) Safety Planning Intervention (SPI), a brief ED-based intervention of a written list prioritizing coping strategies and sources of support to alleviate a suicidal crisis; (3) Making Connections Intervention (MCI), a mental health engagement intervention for Black adolescents and their parents; and (4) a follow-up text messaging support system for youth and parents will be introduced for enhanced feasibility. This study is a randomized clinical effectiveness trial with 2,200 Black youth at risk for suicide to examine the effectiveness of WeCare. Youth, ages 12 to 19 years, enrolled from two hospital EDs in New York City, will be assessed on enrollment for risks associated with suicide. Moderate/high-risk youth will be randomly assigned to WeCare vs. usual services. Survey assessments will be conducted at 3- and 6-month follow-up, with medical record review through 12 months to examine the effectiveness of WeCare and mediators of WeCare effects. The objective is to increase risk identification, treatment referral and engagement, and, in turn, reduce suicidal ideation and behavior among Black youth.

Interventions

BEHAVIORALWeCare

WeCare combines two evidence-based strategies -- universal screening using the Computerized Adaptive Screen for Suicidal Youth and an adapted version of the SAFETY-ACUTE, which incorporates PI Lindsey's extensive work with Black youth, their families, and community stakeholders to develop culturally tailored strategies for addressing treatment barriers.

Sponsors

New York University
Lead SponsorOTHER
University of Michigan
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 19 Years
Healthy volunteers
Yes

Inclusion criteria

adolescent and parent/guardians: * Adolescents aged 12-17 years and their parents or guardians, and adolescents 18-19 years who have the option for their parent or guardian to participate * Having a parent/caregiver present in the ED to consent or available to consent remotely (12-17 year olds, only) * Having a cellular phone with text messaging capacity * Adolescent able to speak English, and understand study questions * Parents able to consent in English, Spanish, French or Creole * Meet screening criteria

Exclusion criteria

adolescent and parent/guardians: * Adolescent is medically unstable * Adolescent present with severe cognitive impairment * Parents are not present in the ED, unable to consent remotely, and not able to give consent in either English, Spanish, French or Creole (12-17 year olds, only) * Adolescent does not have access to cellular phone * Adolescents active in mental health treatment (e.g., seen a therapist, social worker, or mental health provider in the last week)

Design outcomes

Primary

MeasureTime frameDescription
Mental Health Outpatient Visits (Electronic Medical Record)Baseline, Months 3 and 6This measure assesses mental health service utilization from 50 patient care locations in New York City via electronic medical records.
Columbia-Suicide Severity Rating ScaleBaseline, Months 3 and 6This measure is a semi structured interview to assess suicidal ideation and attempt This measure is a semi structured interview to assess suicidal ideation and attempt behavior (actual, interrupted, aborted suicide attempts; preparatory behavior).

Secondary

MeasureTime frameDescription
Attitudes Toward Psychological Help ScaleBaseline, Months 3 and 6This measure assesses psychological factors, including stigma, perceived relevance of treatment, etc. that impact one's perceptions and attitudes about using formal mental health treatment services.
BarriersBaseline, Months 3 and 6This 5-item measure captures barriers to MH treatment participation identified in PI Lindsey's prior work with Black youth and families. A higher score indicates a perception of more barriers to treatment (Minimum score: 5; Maximum score: 15).
Caregiver Knowledge of Mental Health Services (Therapy Survey)Baseline, Months 3 and 6This measures expectations about treatment at a children's psychiatric clinic (caregiver).
ED STARS Mental Health Service UseBaseline, Months 3 and 6This measure assesses mental health service utilization, efforts to link to services, linkage, and engagement with outpatient MH services (caregiver).
HopelessnessBaseline, Months 3 and 6This measure targets recent feelings of hopelessness and hope.
Parent-Family Connectedness ScaleBaseline, Months 3 and 6This measure assesses familial connectedness.
How I Feel about FriendsBaseline, Months 3 and 6This 2-ite, measure assesses peer connectedness. Higher scores indicate greater peer connectedness (Minimum score: 2; Maximum score: 10).
Peer Victimization and PerpetrationBaseline, Months 3 and 6This measure assesses bullying.
Urgency Premeditated Perseverance Sensation Seeking SubscaleBaseline, Months 3 and 6This measure assesses impulsivity.
Mental Health Service UseBaseline, Months 3 and 6This measure assesses lifetime mental health service use (caregiver).
Stages of ChangeBaseline, Months 3 and 6This 8-item measure assesses adolescents' willingness to change (Minimum score: 8; Maximum score: 32).
Barriers to Treatment Participation ScaleBaseline, Months 3 and 6This measure assesses barriers to treatment (caregiver).

Countries

United States

Contacts

CONTACTMichael A Lindsey, PhD
michael.lindsey@nyu.edu(212) 998-5959
CONTACTJacqueline Holloway, PhD
jacqueline.holloway@nyu.edu973-941-2376
PRINCIPAL_INVESTIGATORMichael A Lindsey, PhD

New York University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 11, 2026